33: Episode 33 - Christy Figueredo - Navigating GLP-1 Use in Pediatrics Episode 33 - Christy Figueredo - Navigating GLP-1 Use in Pediatrics In this episode of Nutrition Pearls: the Podcast, co-hosts
This aligns with concepts of compartmentalized and biased receptor signaling, where selective pathway engagement could influence functional outcomes
Respuesta Rpida: Los medicamentos GLP-1 pueden no funcionar adecuadamente debido a dosis inadecuada, tiempo insuficiente de tratamiento, tcnica de administracin incorrecta, falta de adherencia, o factores individuales como condiciones mdicas coexistentes y hbitos de estilo de vida
4.1 Future clinical and research applications 4.1.1 Future research directions While reassuring data are accumulating about the safety profile of GLP-1 receptor agonists (GLP-1 RAs) used for diabetes and obesity management, there are still significant gaps in our understanding that justifies the need for well-designed multidisciplinary translational and clinical studies
Despite evidence that weight loss improves obesity-related complications, the age-adjusted prevalence of obesity in US adults in 20172018 was 42.4% [2], indicating an unmet need in the management of obesity